Navigation Links
Raptor Pharmaceuticals Expands Board of Directors and Scientific Advisory Board
Date:7/14/2008

healthcare consulting firm, Richard Franklin & Associates, and led the Healthcare Corporate Finance Team at Tucker Anthony, an investment bank. He received a bachelor's degree from Harvard University, an M.A. in mathematics from the University of Washington, a Ph.D. in mathematics from Brandeis University, and an M.D. from Boston University School of Medicine.

Dr. Franklin stated, "As a member of Raptor's board of directors, I look forward to counseling the Company on maximizing the pipeline's potential and delivering value to stockholders. Raptor's scientific expertise and drug discovery capabilities, coupled with a focus on mid-stage clinical studies evaluating novel formulations of existing drugs, strikes the right balance. The drug development risks inherent in preclinical programs are nicely offset by the recently acquired clinical programs focused on reformulating currently approved therapies with known safety profiles and repurposing approved therapies for new indications."

Dr. Blacklow contributes scientific exerptise from academia to Raptor's scientific advisory board. He is an Associate Professor of Pathology and a Director of the M.D. Ph.D. program, basic sciences track, at Harvard Medical School. He also directs a research laboratory at the Brigham and Women's Hospital, a teaching affiliate of Harvard Medical School. Recently, Dr. Blacklow's team determined the structure of the RAP d3 protein complexed with receptor. Over the last ten years, Dr. Blacklow's research team has achieved international recognition for mechanistic and structural studies of low-density lipoprotein or LDL receptor proteins, and for work on the structure and function of human Notch proteins. Dr. Blacklow received his M.D. and Ph.D. in bioorganic chemistry from Harvard University in 1991.

About Raptor Pharmaceuticals Corp.

Raptor Pharmaceuticals Corp. ("Raptor") is a development-stage biopharmaceutical company leveraging novel drug-targeting platforms a
'/>"/>

SOURCE Raptor Pharmaceuticals Corp.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Raptor Pharmaceuticals Closes $10 Million Private Placement
2. Raptor Pharmaceuticals Corp. Announces Presentation at 5th International Cystinosis Conference 2008
3. Raptor Pharmaceuticals Corp. To Present at BIO 2008 International Convention
4. Raptor Pharmaceuticals Corp. Receives FDA Orphan Drug Designation for Cysteamine in Huntingtons Disease
5. Raptor Pharmaceuticals Corp. Enters Agreements to Advance Clinical Pipeline
6. Raptor Pharmaceuticals Acquires Orphan Clinical Program
7. WuXi PharmaTech (NYSE: WX) Wins the 2008 Frost & Sullivan Award for Best in Class Outsourced R&D in Pharmaceuticals and Biotechnology
8. Access Pharmaceuticals Signs Merger Agreement to Acquire MacroChem Corp.
9. Alexion Pharmaceuticals Invites You to Participate in its Second Quarter 2008 Results Conference Call and Web Cast
10. Pacira Pharmaceuticals, Inc. Adds Board Member and Key Senior Management
11. Christopher Kurtz Joins Alexza Pharmaceuticals as Vice President, Global Supply Chain and Sustainment Engineering
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2014)... 2014 Continental Clinical Solutions, LLC ... clinical trials at its mid-Atlantic late-phase research facility, ... created with the idea of closing patient disparities ... in medical advances," said Continental's CEO, Saleh ... the immortal cell line of Henrietta Lacks, dubious ...
(Date:11/24/2014)... , Nov. 24, 2014  Spherix Incorporated ... company committed to the fostering and monetization of ... v. VTech Telecommunications Ltd.,  Case No. 3:13-cv-03494-M and  ... No. 3:13-cv-03496-M, both in the United States District ... Texas . On November ...
(Date:11/22/2014)... Two new educational webinars hosted by DrugDev ... research and how the pharmaceutical industry can make life easier ... Where Does the ALS Money Go? , Featuring guest speaker ... 1:30pm ET, Register to attend , This webinar ... Julianne Dorn Professor of Neurology at Massachusetts General Hospital at ...
(Date:11/22/2014)... November 21, 2014 CannLabs, Inc. ... based analytics and scientific testing methodologies relating to cannabis, ... a $750,000 line of credit from an existing stockholder ... to have secured this commitment from one of our ... of CannLabs. “This capital will help accelerate our planned ...
Breaking Biology Technology:At Continental Clinical Solutions, CEO Saleh Stevens Focuses on Diversity in Clinical Trial Recruitment at Maryland Site 2At Continental Clinical Solutions, CEO Saleh Stevens Focuses on Diversity in Clinical Trial Recruitment at Maryland Site 3Markman Hearing Held as Scheduled in VTech and Uniden Cases 2DrugDev Webinars in December to Explore What Comes Next for ALS Research and How We Can Make Life Easier for Clinical Sites 2CannLabs Secures $750,000 Line Of Credit 2
... National Institutes of Health. Madison, Wis. ... on Wednesday that it will receive a $1.26 million Phase ... of Health. , ,The funds will be used to help ... blood disorder that kills red blood cells. This results in ...
... conference at Grainger Hall. Madison, Wis. ... Wisconsin, according to the Coalition for Capital Growth and Research, ... Hall. , ,We believe [venture capital] is a worthwhile agenda ... partner at Venture Investors and the conferences founder. ...
... Teresa Esser Pel-Freez Clinical Systems, LLC began as ... flourished during the World Wars because unlike other meats, ... Pel-Freez Rabbit Meat, Inc. relocated to Rogers, Arkansas, because ... , ,During the 1960s, the companys managers realized that ...
Cached Biology Technology:Mirus receives $1.26 million SBIR grant to combat anemia 2Wisconsin investors seek regional partners and informed legislature 2Wisconsin investors seek regional partners and informed legislature 3An entrepreneurial success story Frank Langley champions biocapitalism 2An entrepreneurial success story Frank Langley champions biocapitalism 3An entrepreneurial success story Frank Langley champions biocapitalism 4An entrepreneurial success story Frank Langley champions biocapitalism 5
(Date:11/18/2014)... Md. , Nov. 17, 2014 The Parenteral ... and U.S. regulatory agencies will speak and at least seven ... Metrics Conference at the Omni Shoreham Hotel in ... pleased once again to have significant support from the regulatory ... Europe in our effort to help ...
(Date:11/10/2014)... on U.S. store shelves in early 2010, and people ... small packets can be tossed into a washing machine ... powder. The convenience, though, has come with risks for ... Nationwide Children,s Hospital found that from 2012 through 2013, ... younger than 6 years of age swallowing, inhaling, or ...
(Date:11/6/2014)... deaths occur because of metastasis, yet progress in ... slow. , "It,s been particularly challenging to design ... research fellow in systems biology at Harvard Medical ... until after they,ve already metastasized." , Gujral and ... should help researchers better understand how metastasis begins. ...
Breaking Biology News(10 mins):FDA's Janet Woodcock, EMA's Emer Cooke Headline PDA Quality Metrics Conference 2Study finds laundry detergent pods, serious poisoning risk for children 2Migration negation 2Migration negation 3
... detailed analysis to date of how humans differ from one ... selection has shaped the recent evolution of our species, according ... , In a study published in the Oct. 20 ... comparing how genes vary not only among 39 humans but ...
... found only in hops and the main product they are ... a micronutrient that might help prevent many types of cancer. ... properties of this flavonoid compound called xanthohumol about 10 years ... journal Phytochemistry outlines the range of findings made since then. ...
... A human DNA-associated protein called LEDGF is the first ... integration in human cells, according to a new study ... Medicine. , This study, published in this week's early ... target for modulating where viruses insert into the human ...
Cached Biology News:Cornell finds natural selection in humans 2Cornell finds natural selection in humans 3Anti-cancer Compound In Beer Gaining Interest 2Anti-cancer Compound In Beer Gaining Interest 3HIV inserts into human genome using a DNA-associated protein 2
... Mouse monoclonal [PRMT5-21] to PRMT5 ... modification which has only recently been linked ... of PRMT enzymes have been identified in ... to have essential regulatory functions by methylation ...
... Roches RTS AviTag E. coli Biotinylation Kit, Plasmid ... and 500 E. coli expression kits. (Cat. No. ... 461). This kit provides vectors for the easy ... sequence. The expressed protein can be enzymatically mono-biotinylated ...
... pathway is the major proteolytic system ... where it catalyzes the selective degradation ... rapid elimination of proteins with abnormal ... 1996). The critical protease in this ...
... sensitive, fast and specific detection of chromosomal ... Short hybridisation time ( ... Multiplex capability Available with different ... Probes available with different labels. Related ...
Biology Products: